XBiotech (XBIT) SEC Filings & 10K Form

$8.16
+0.49 (+6.39%)
(As of 05/1/2024 ET)

Recent XBiotech SEC Filings

DateFilerForm TypeView
03/15/2024
2:31 PM
XBiotech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/07/2024
11:36 AM
SIMARD JOHN (Filed by)
XBiotech (Subject)
XBiotech (Subject)
Form SC 13G/A
02/07/2024
11:01 AM
MCKENZIE W THORPE (Filed by)
XBiotech (Subject)
Form SC 13G/A
02/07/2024
11:01 AM
GUT THOMAS (Filed by)
XBiotech (Subject)
Form SC 13G/A
01/05/2024
9:48 AM
SIMARD JOHN (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
8:00 AM
XBiotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
1:41 PM
XBiotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/11/2023
10:18 AM
XBiotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/26/2023
7:47 AM
Waldin Jan-Paul (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
7:40 AM
MCKENZIE W THORPE (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
7:43 AM
MacAdam Donald H. (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2023
7:45 AM
Libby Peter (Reporting)
XBiotech (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
2:03 PM
XBiotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
8:19 AM
XBiotech (Subject)
Form SC TO-I/A
05/17/2023
8:21 AM
XBiotech (Subject)
Form SC TO-I
05/10/2023
2:41 PM
XBiotech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:XBIT) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners